36 / 76
CARDIOVASCULAR JOURNAL OF AFRICA • Volume 29, No 3, May/June 2018
166
AFRICA
943–951.
11. Gori T, Muxel S, Damaske A, Radmacher MC, Fasola F, Schaefer
S,
et al
. Endothelial function assessment: flow-mediated dilation and
constriction provide different and complementary information on the
presence of coronary artery disease.
Eur Heart J
2012;
33
(3): 363–371.
12. Manganaro A, Ciracì L, Andrè L, Trio O, Manganaro R, Saporito F,
et al
. Endothelial dysfunction in patients with coronary artery disease:
insights from a flow-mediated dilation study.
Clin Appl Thromb Hemost
2014;
20
(6): 583–588.
13. Liu Z, Zhao Y, Lu F, Zhang H, Diao Y. Day-by-day variability in self-
measured blood pressure at home: effects on carotid artery atheroscle-
rosis, brachial flow-mediated dilation, and endothelin-1 in normotensive
and mild-moderate hypertensive individuals.
Blood Press Monit
2013;
18
: 316–325.
14. Beyer AM, Zinkevich N, Miller B, Liu Y, Wittenburg AL, Mitchell M,
et al.
Transition in the mechanism of flow-mediated dilation with aging
and development of coronary artery disease.
Basic Res Cardiol
2017;
112
(1): 5.
15. Schuster H, Barter PJ, Stender S, Cheung RC, Bonnet J, Morrell
JM,
et al
. Effects of switching statins on achievement of lipid goals:
Measuring Effective Reductions in Cholesterol Using Rosuvastatin
Therapy (MERCURY I) study.
Am Heart J
2004;
147
(4): 705–713.
16. Insull W Jr, Ghali JK, Hassman DR, Y As JW, Gandhi SK, Miller E.
Achieving low-density lipoprotein cholesterol goals in high-risk patients
in managed care: comparison of rosuvastatin, atorvastatin, and simvas-
tatin in the SOLAR trial.
Mayo Clin Proc
2007;
82
(5): 543–550.
17. Meor Anuar Shuhaili MFR, Samsudin IN, Stanslas J, Hasan S,
Thambiah SC. Effects of different types of statins on lipid profile: a
perspective on Asians.
Int J Endocrinol Metab
2017;
15
(2): e43319.
18. McTaggart F, Jones P. Effects of statins on high-density lipoproteins: a
potential contribution to cardiovascular benefit.
Cardiovasc Drugs Ther
2008;
22
(4): 321–338.
19. Zhou B, Ren C, Zu L, Zheng L, Guo L, Gao W. Elevated plasma migra-
tion inhibitory factor in hypertension-hyperlipidemia patients correlates
with impaired endothelial function.
Medicine
(Baltimore) 2016;
95
(43):
e5207.
20. Sawada T, Tsubata H, Hashimoto N, Takabe M, Miyata T, Aoki K,
et
al
. Effects of 6-month eicosapentaenoic acid treatment on postprandial
hyperglycemia, hyperlipidemia, insulin secretion ability, and concomi-
tant endothelial dysfunction among newly-diagnosed impaired glucose
metabolism patients with coronary artery disease. An open label, single
blinded, prospective randomized controlled trial.
Cardiovasc Diabetol
2016;
15
(1): 121.
21. Higashi Y, Sanada M, Sasaki S, Nakagawa K, Goto C, Matsuura H,
et al
. Effect of estrogen replacement therapy on endothelial function
in peripheral resistance arteries in normotensive and hypertensive post-
menopausal women.
Hypertension
2001;
37
(2 Part 2): 651–657.
22. Kawano H, Motoyama T, Hirashima O, Hirai N, Miyao Y, Sakamoto
T,
et al.
Hyperglycemia rapidly suppresses flow-mediated endothelium-
dependent vasodilation of brachial artery.
J Am Coll Cardiol
1999;
34
(1): 146–154.
23. Harrison DG, Armstrong ML, Freiman PC, Heistad DD. Restoration
of endothelium-dependent relaxation by dietary treatment of athero-
sclerosis.
J Clin Invest
1987;
80
(6): 1808–1811.
24. John S, SchlaichM, LangenfeldM, Weihprecht H, Schmitz G, Weidinger
G,
et al
. Increased bioavailability of nitric oxide after lipid-lowering
therapy in hypercholesterolemic patients: a randomized, placebo-
controlled, double-blind study.
Circulation
1998;
98
(3): 211–216.
25. Baspınar O, Bayram F, Korkmaz S, Aksu M, Kocer D, Dizdar OS,
et al
.
The effects of statin treatment on adrenal and sexual function and nitric
oxide levels in hypercholesterolemic male patients treated with a statin.
J Clin Lipidol
2016;
10
(6): 1452–1461.
26. Marchesi S, Lupattelli G, Siepi D, Schillaci G, Vaudo G, Roscini AR,
et al.
Short-term atorvastatin treatment improves endothelial function
in hypercholesterolemic women.
J Cardiovasc Pharmacol
2000;
36
(5):
617–621.